C-19 Injections: Massive Regulatory and Manufacturing Fraud

Ex-pharmaceutical industry and biotech executive Alexandra Latypova shares hers findings.

By: Tessa Lena

STORY AT-A-GLANCE

• Alexandra Latypova is an ex-pharmaceutical industry and biotech executive with a lot of experience in the areas of drug safety and clinical trials

• Early on, she discovered that, based on the number of reported deaths and adverse events per lot, there was unprecedented variability in the toxicity of the product

• According to A…